Dataset Information


IL-21 promotes CD4 T cell responses by phosphatidylinositol 3-kinase-dependent upregulation of CD86 on B cells.

ABSTRACT: The cytokine IL-21 is a potent immune modulator with diverse mechanisms of action on multiple cell types. IL-21 is in clinical use to promote tumor rejection and is an emerging target for neutralization in the setting of autoimmunity. Despite its clinical potential, the biological actions of IL-21 are not yet fully understood and the full range of effects of this pleiotropic cytokine are still being uncovered. In this study, we identify a novel role for IL-21 as an inducer of the costimulatory ligand CD86 on B lymphocytes. CD86 provides critical signals through T cell-expressed CD28 that promote T cell activation in response to Ag engagement. Expression levels of CD86 are tightly regulated in vivo, being actively decreased by regulatory T cells and increased in response to pathogen-derived signals. In this study, we demonstrate that IL-21 can trigger potent and sustained CD86 upregulation through a STAT3 and PI3K-dependent mechanism. We show that elevated CD86 expression has functional consequences for the magnitude of CD4 T cell responses both in vitro and in vivo. These data pinpoint CD86 upregulation as an additional mechanism by which IL-21 can elicit immunomodulatory effects.

SUBMITTER: Attridge K 

PROVIDER: S-EPMC3932810 | BioStudies | 2014-01-01

REPOSITORIES: biostudies

Similar Datasets

2013-01-01 | S-EPMC3538926 | BioStudies
2011-01-01 | S-EPMC4496154 | BioStudies
2018-01-01 | S-EPMC5980965 | BioStudies
2012-01-01 | S-EPMC3433478 | BioStudies
2016-01-01 | S-EPMC4726240 | BioStudies
2018-01-01 | S-EPMC6153729 | BioStudies
1000-01-01 | S-EPMC3342005 | BioStudies
2016-01-01 | S-EPMC4862702 | BioStudies
1000-01-01 | S-EPMC6202843 | BioStudies
2017-01-01 | S-EPMC5450507 | BioStudies